Cochrane Abstracts
Multiple drug combinations of bortezomib, lenalidomide, and thalidomide for first‐line treatment in adults with transplant‐ineligible multiple myeloma: a network meta‐analysis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Multiple Drug Combinations of Bortezomib, Lenalidomide, and Thalidomide for First‐line Treatment in Adults With Transplant‐ineligible Multiple Myeloma: a Network Meta‐analysis." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434607/all/Multiple_drug_combinations_of_bortezomib__lenalidomide__and_thalidomide_for_first‐line_treatment_in_adults_with_transplant‐ineligible_multiple_myeloma:_a_network_meta‐analysis_Edited__no_change_to_conclusions_. Accessed 08 December 2023.
Multiple drug combinations of bortezomib, lenalidomide, and thalidomide for first‐line treatment in adults with transplant‐ineligible multiple myeloma: a network meta‐analysis. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434607/all/Multiple_drug_combinations_of_bortezomib__lenalidomide__and_thalidomide_for_first‐line_treatment_in_adults_with_transplant‐ineligible_multiple_myeloma:_a_network_meta‐analysis_Edited__no_change_to_conclusions_. Accessed December 8, 2023.
Multiple drug combinations of bortezomib, lenalidomide, and thalidomide for first‐line treatment in adults with transplant‐ineligible multiple myeloma: a network meta‐analysis. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434607/all/Multiple_drug_combinations_of_bortezomib__lenalidomide__and_thalidomide_for_first‐line_treatment_in_adults_with_transplant‐ineligible_multiple_myeloma:_a_network_meta‐analysis_Edited__no_change_to_conclusions_
Multiple Drug Combinations of Bortezomib, Lenalidomide, and Thalidomide for First‐line Treatment in Adults With Transplant‐ineligible Multiple Myeloma: a Network Meta‐analysis [Internet]. In: Cochrane Abstracts. [cited 2023 December 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434607/all/Multiple_drug_combinations_of_bortezomib__lenalidomide__and_thalidomide_for_first‐line_treatment_in_adults_with_transplant‐ineligible_multiple_myeloma:_a_network_meta‐analysis_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Multiple drug combinations of bortezomib, lenalidomide, and thalidomide for first‐line treatment in adults with transplant‐ineligible multiple myeloma: a network meta‐analysis
ID - 434607
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434607/all/Multiple_drug_combinations_of_bortezomib__lenalidomide__and_thalidomide_for_first‐line_treatment_in_adults_with_transplant‐ineligible_multiple_myeloma:_a_network_meta‐analysis_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -
